Neogen Stock Price Patterns
| NEOG Stock | USD 9.68 -0.02 -0.21% |
Momentum 69
Buy Stretched
Oversold | Overbought |
Quarterly Earnings Growth -0.86 | EPS Estimate Current Year 0.3567 | EPS Estimate Next Year 0.3233 | Wall Street Target Price 11.6667 | EPS Estimate Current Quarter 0.0667 |
The hype view outlines Neogen's attention response alongside peer coverage. This view uses options positioning and short interest to outline sentiment around Neogen.
Short Interest Panel - Neogen
Changes in Neogen's short interest are tracked as sentiment context. This context is presented alongside price and volatility signals.
200 Day MA 6.7149 | Short Percent 0.0643 | Short Ratio 3.22 | Shares Short Prior Month 11.9 M | 50 Day MA 9.7564 |
Neogen Hype-Price Mapping
Average sentiment around Neogen is summarized to provide attention context. The view connects attention signals with observed price behavior.
This view compares attention trends with price response for Neogen. The context can be compared with fundamentals and volatility metrics.
Neogen Implied Volatility | 1.28 |
Neogen's implied volatility provides a volatility expectation derived from option pricing. The measure is presented as informational context for volatility interpretation.
The attention view for Neogen connects headline intensity with short-term volatility context.
Neogen after-hype prediction price | USD 9.72 |
The sentiment summary complements forecasting and technical views with analyst estimates and earnings data.
Rule 16 Reference for the current Neogen contract - Market Context
Based on Rule 16, the market-implied daily move for 2026-04-17 options is about 0.08%. At a recent price around USD 9.68, the implied daily move is approximately USD 0.01, which is informational only.
Cross-verify projections for Neogen using Neogen Basic Forecasting Models. The model set adds a statistical reference.Investors who believe in mean reversion view Neogen's price extremes not as permanent states but as temporary dislocations that create opportunities for disciplined, contrarian capital allocation.
Neogen After-Hype Price Density Analysis
The shape of Neogen's price distribution after major news events tends to be skewed, with larger potential moves to the downside than to the upside for established companies like Neogen. This asymmetry is a key input for options pricing and risk management.
Next price density |
| Expected price to next headline |
Neogen Estimiated After-Hype Price Volatility
By studying Neogen's historical news reactions, we generate empirical estimates of the price boundaries that follow significant headlines. Neogen's after-hype downside and upside margins for the prediction period are 5.02 and 14.42, respectively. These estimates are most reliable when Neogen's news reaction patterns have been consistent over multiple events.
Current Value
The after-hype framework applied to Neogen assumes a 3 months review window and focuses on post-sentiment normalization rather than raw momentum. This view is most useful when investors want to compare sentiment-driven price extension with a more measured post-news scenario.
Neogen Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Neogen is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Neogen backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Neogen, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.78 | 4.70 | 0.04 | 0.47 | 11 Events | 8 Events | In 11 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
9.68 | 9.72 | 0.41 |
|
Neogen Hype Timeline
Neogen is now traded for 9.68. The entity has historical hype elasticity of 0.04, and average elasticity to hype of competition of 0.47. Neogen is estimated to increase in value after the next headline, with the price projected to jump to 9.72 or above. The average volatility of media hype impact on the company the price is over 100%. The price rise on the next news is projected to be 0.41%, whereas the daily expected return is now at 0.78%. The volatility of related hype on Neogen is about 782.03%, with the expected price after the next announcement by competition of 10.15. The company reported the previous year's revenue of 894.66 M. Net Loss for the year was -1.09 B with profit before overhead, payroll, taxes, and interest of 404.77 M. Given the investment horizon of 90 days the next estimated press release will be in 11 days. Cross-verify projections for Neogen using Neogen Basic Forecasting Models. The model set adds a statistical reference.Neogen Related Hype Analysis
News about regulatory changes, technological disruptions, or macroeconomic shifts can affect Neogen's entire competitive landscape simultaneously. Monitoring peer reactions to such events helps investors anticipate Neogen's likely response.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| OPK | Opko Health | 0.01 | 9 per month | 0.00 | -0.08 | 3.03 | -3.08 | 11.14 | |
| AZTA | Azenta Inc | 1.36 | 8 per month | 0.00 | -0.13 | 3.44 | -5.03 | 29.88 | |
| NVCR | Novocure | 0.50 | 8 per month | 4.10 | 0.05 | 6.92 | -8.27 | 35.96 | |
| TLRY | Tilray Inc | -0.10 | 11 per month | 4.28 | 0.02 | 7.64 | -7.60 | 54.17 | |
| KMTS | Kestra Medical Technologies | -1.45 | 10 per month | 0.00 | -0.02 | 5.06 | -5.85 | 20.54 | |
| BLFS | BioLife Solutions | 0.26 | 10 per month | 0.00 | -0.12 | 3.19 | -4.27 | 18.09 | |
| ZBIO | Zenas BioPharma Common | 2.09 | 9 per month | 0.00 | -0.01 | 12.20 | -11.66 | 68.95 | |
| UPB | Upstream Bio | 2.26 | 9 per month | 0.00 | -0.19 | 7.79 | -12.87 | 55.72 | |
| CNMD | CONMED | 0.89 | 11 per month | 0.00 | -0.06 | 3.36 | -3.89 | 11.74 | |
| NTLA | Intellia Therapeutics | 0.19 | 10 per month | 4.25 | 0.16 | 10.73 | -6.81 | 25.18 |
Neogen Additional Predictive Modules
Most predictive techniques to examine Neogen price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Neogen using various technical indicators. When you analyze Neogen charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
What Is the Market Saying About Neogen?
Sentiment analysis for Neogen evaluates news tone, positioning, and narrative momentum. Momentum often follows narrative shifts when liquidity is supportive. We review the company from a portfolio-construction standpoint emphasizing diversification and stability.
Methodology
Unless otherwise specified, financial data for Neogen is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Neogen (USA Stocks:NEOG) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions Analyst consensus data and sentiment signals are derived from publicly available research and media sources and reflect a point-in-time view.
Assumptions
Macroaxis analytics incorporate public filings and market reference sources and official disclosures from U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Food & Drug Administration (FDA). Data harmonization may result in minor timing offsets. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.Analyst Sources
Neogen is covered by 4 analysts. 2 analysts have submitted revenue and/or earnings estimates that may be incorporated into Macroaxis consensus inputs where available. Representative analyst firms may include Morgan Stanley, Goldman Sachs, Citigroup, Raymond James, Deutsche Bank, among others. Updates may occur throughout the day.
Currently Active Assets on Macroaxis
Popular Tools for Neogen Stock analysis
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |